Las Vegas, NV -- (SBWIRE) -- 10/03/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: SanDisk Corporation (NASDAQ:SNDK), Youku Tudou Inc (ADR) (NYSE:YOKU), New Gold Inc. (USA)(NYSEMKT:NGD), Celldex Therapeutics, Inc. (NASDAQ:CLDX)
SanDisk Corporation (NASDAQ:SNDK) managed to keep its gain at 2.35% on above-normal volume of 4.61M shares. The stock settled at $61.48 after floating in a range of $59.65 to $61.94. Its latest price has reached market capitalization of $14.78 billion. Its 52-week range has been $38.47 to $63.97. Sandisk Corporation designs, develops, manufactures, and markets flash storage card products that are used in various consumer electronics products.
For How Long SNDK will fight for Profitability? Read This Trend Analysis report
Youku Tudou Inc (ADR) (NYSE:YOKU) traded up on a volume of 4.60 million, higher than its standard daily volume. Shares have gained 4.12% to $29.84. Over the last twelve months, the stock has gained 62.26% and faced a worst price of $13.82. Youku Tudou Inc. operates as an Internet television company in the People?s Republic of China. Its Internet television platform enables consumers to search, view, and share video content across various devices.
For How Long YOKU’s Gloss will Attract Investors? Find out via this report
New Gold Inc. (USA)(NYSEMKT:NGD) settled 1.36% higher at $5.97 on below -normal volume of 4.52M shares during the last trading day. The stock has its 12-month high at $12.70 and 52-week low price was $5.70. It traded in a range of $5.94 to $6.11 during the last trading day. New Gold Inc., a gold mining company, engages in the acquisition, exploration, extraction, processing, and reclamation of mineral properties. It primarily explores for gold, silver, and copper deposits.
Why Should Investors Buy NGD After the Recent Fall? Just Go Here and Find Out
In the last trading session, Celldex Therapeutics, Inc. (NASDAQ:CLDX) was down on high volume, trading at a volume of 4.52M shares versus its average daily volume of 2.41 million shares. At $36.71, the stock has attained market capitalization of $2.97 billion. Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States.
Why Should Investors Buy CLDX After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)